UNIFLU

This brand name is authorized in Malta.

Active ingredients

The drug UNIFLU contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 362O9ITL9D - ACETAMINOPHEN
 

Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain.

 
Read more about Paracetamol
2
UNII 04JA59TNSJ - PHENYLEPHRINE HYDROCHLORIDE
 

Phenylephrine is a sympathomimetic agent with mainly direct effects on adrenergic receptors. It has predominantly alpha adrenergic activity and is without stimulating effects on the central nervous system. The sympathomimetic effect of phenylephrine produces vasoconstriction which in turn relieves nasal congestion.

 
Read more about Phenylephrine
3
UNII 3G6A5W338E - CAFFEINE
 

Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant.

 
Read more about Caffeine
4
UNII TC2D6JAD40 - DIPHENHYDRAMINE HYDROCHLORIDE
 

Diphenhydramine is an ethanolamine-derivative antihistamine. It is an antihistamine with anticholinergic and marked sedative effects. It acts by inhibiting the effects on H1-receptors. Diphenhydramine is effective in reducing sleep onset (i.e., time to fall asleep) and increasing the depth and quality of sleep.

 
Read more about Diphenhydramine
5
UNII GSL05Y1MN6 - CODEINE PHOSPHATE
 

Codeine is a centrally acting weak analgesic. Codeine exerts its effect through μ opioid receptors, although codeine has low affinity for these receptors, and its analgesic effect is due to its conversion to morphine. Codeine, particularly in combination with other analgesics such as paracetamol, has been shown to be effective in acute nociceptive pain. The anti-tussive activity of codeine is probably due to its depressant effect on the medullary cough centre in the brain.

 
Read more about Codeine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R05X Other cold preparations R Respiratory system → R05 Cough and cold preparations
Discover more medicines within R05X

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
MT Medicines Authority MA1333/00401

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.